全文获取类型
收费全文 | 1604篇 |
免费 | 135篇 |
国内免费 | 22篇 |
专业分类
儿科学 | 30篇 |
妇产科学 | 15篇 |
基础医学 | 233篇 |
口腔科学 | 19篇 |
临床医学 | 151篇 |
内科学 | 301篇 |
皮肤病学 | 26篇 |
神经病学 | 227篇 |
特种医学 | 97篇 |
外科学 | 206篇 |
综合类 | 29篇 |
预防医学 | 125篇 |
眼科学 | 32篇 |
药学 | 148篇 |
中国医学 | 1篇 |
肿瘤学 | 121篇 |
出版年
2023年 | 9篇 |
2022年 | 21篇 |
2021年 | 26篇 |
2020年 | 14篇 |
2019年 | 35篇 |
2018年 | 37篇 |
2017年 | 22篇 |
2016年 | 40篇 |
2015年 | 50篇 |
2014年 | 50篇 |
2013年 | 55篇 |
2012年 | 70篇 |
2011年 | 76篇 |
2010年 | 57篇 |
2009年 | 74篇 |
2008年 | 82篇 |
2007年 | 81篇 |
2006年 | 80篇 |
2005年 | 65篇 |
2004年 | 57篇 |
2003年 | 47篇 |
2002年 | 55篇 |
2001年 | 57篇 |
2000年 | 48篇 |
1999年 | 49篇 |
1998年 | 34篇 |
1997年 | 35篇 |
1996年 | 25篇 |
1995年 | 18篇 |
1994年 | 32篇 |
1993年 | 25篇 |
1992年 | 24篇 |
1991年 | 21篇 |
1990年 | 15篇 |
1989年 | 22篇 |
1988年 | 12篇 |
1987年 | 21篇 |
1986年 | 25篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 17篇 |
1982年 | 8篇 |
1980年 | 6篇 |
1978年 | 8篇 |
1974年 | 10篇 |
1973年 | 7篇 |
1972年 | 8篇 |
1971年 | 11篇 |
1970年 | 7篇 |
1965年 | 6篇 |
排序方式: 共有1761条查询结果,搜索用时 15 毫秒
51.
52.
Leibetseder Annette Leitner Johannes Mair Maximilian J. Meckel Stephan Hainfellner Johannes A. Aichholzer Martin Widhalm Georg Dieckmann Karin Weis Serge Furtner Julia von Oertzen Tim Preusser Matthias Pichler Josef Berghoff Anna Sophie 《Journal of neurology》2022,269(3):1574-1590
Journal of Neurology - Adult brainstem gliomas (BSGs) are rare central nervous system tumours characterized by a highly heterogeneous clinical course. Median survival times range from 11 to... 相似文献
53.
Thymomas are rare tumors but are one of the most common mediastinal neoplasms in adults and exhibit an enormous variability in histological, biological and genetic features. The morphological spectrum within a given entity is enormous and some tumors with histological patterns of more than one entity are more common than pure histological subtypes. Due to a lack of subtype-specific markers classification of thymomas often requires complex diagnostic algorithms. The refined presentation including the definition of obligatory and optional features and of diagnostic immunohistochemical profiles, is the focus of the new World Health Organization (WHO) classification of thymomas, aiming at improving diagnostic reproducibility. This review highlights novel aspects of the WHO classification of thymomas and addresses typical differential diagnostic challenges with a focus on diagnostic pitfalls. 相似文献
54.
Ronald T. Toth Samantha E. Pace Brittney J. Mills Sangeeta B. Joshi Reza Esfandiary C. Russell Middaugh David D. Weis David B. Volkin 《Journal of pharmaceutical sciences》2018,107(4):1009-1019
Antibodies are molecules that exhibit diverse conformational changes on different timescales, and there is ongoing interest to better understand the relationship between antibody conformational dynamics and storage stability. Physical stability data for an IgG4 monoclonal antibody (mAb-D) were gathered through traditional forced degradation (temperature and stirring stresses) and accelerated stability studies, in the presence of different additives and solution conditions, as measured by differential scanning calorimetry, size exclusion chromatography, and microflow imaging. The results were correlated with hydrogen exchange mass spectrometry (HX-MS) data gathered for mAb-D in the same formulations. Certain parameters of the HX-MS data, including hydrogen exchange in specific peptide segments in the CH2 domain, were found to correlate with stabilization and destabilization of additives on mAb-D during thermal stress. No such correlations between mAb physical stability and HX-MS readouts were observed under agitation stress. These results demonstrate that HX-MS can be set up as a streamlined methodology (using minimal material and focusing on key peptide segments at key time points) to screen excipients for their ability to physically stabilize mAbs. However, useful correlations between HX-MS and either accelerated or real-time stability studies will be dependent on a particular mAb's degradation pathway(s) and the type of stresses used. 相似文献
55.
Apurva S. More Ronald T. Toth Solomon Z. Okbazghi C. Russell Middaugh Sangeeta B. Joshi Thomas J. Tolbert David B. Volkin David D. Weis 《Journal of pharmaceutical sciences》2018,107(9):2315-2324
We have used hydrogen exchange–mass spectrometry to characterize local backbone flexibility of 4 well-defined IgG1-Fc glycoforms expressed and purified from Pichia pastoris, 2 of which were prepared using subsequent in vitro enzymatic treatments. Progressively decreasing the size of the N-linked N297 oligosaccharide from high mannose (Man8-Man12), to Man5, to GlcNAc, to nonglycosylated N297Q resulted in progressive increases in backbone flexibility. Comparison of these results with recently published physicochemical stability and Fcγ receptor binding data with the same set of glycoproteins provide improved insights into correlations between glycan structure and these pharmaceutical properties. Flexibility significantly increased upon glycan truncation in 2 potential aggregation-prone regions. In addition, a correlation was established between increased local backbone flexibility and increased deamidation at asparagine 315. Interestingly, the opposite trend was observed for oxidation of tryptophan 277 where faster oxidation correlated with decreased local backbone flexibility. Finally, a trend of increasing C'E glycopeptide loop flexibility with decreasing glycan size was observed that correlates with their FcγRIIIa receptor binding properties. These well-defined IgG1-Fc glycoforms serve as a useful model system to identify physicochemical stability and local backbone flexibility data sets potentially discriminating between various IgG glycoforms for potential applicability to future comparability or biosimilarity assessments. 相似文献
56.
Kenneth Hugdahl Karsten Specht Eva Biringer Susanne Weis Rebecca Elliott Åsa Hammar Lars Ersland Anders Lund 《Cognitive therapy and research》2007,31(2):147-160
Nine patients with unipolar major depression were scanned with MRI twice over a 2-year period, and compared with 12 healthy
control subjects. All patients fulfilled criteria for major depressive disorder, recurrent type, at first scanning. Level
of depressive psychopathology was assessed by the Hamilton Depression Rating Scale. The participants had to work on a mental
arithmetics/working memory task while in the MR scanner. The task consisted of single digits (1 to 9) that were shown to the
participant, who had to add the numbers in successive pairs and press a response button when the sum was 10. Neuronal activation
was recorded based on the BOLD contrast phenomenon in a functional MRI protocol. The results showed significant increase in
activation for the patients in the inferior frontal gyrus and the superior and inferior parietal lobule at the second compared
with the first MR scanning session. There were also significant correlations between the HDRS scores and neuronal activation
which showed a negative correlation particularly in the inferior frontal and parietal lobe areas, which overlapped with similar
areas activated in the healthy control participants. This may indicate normalization of brain activation in depressed patients
as a function of time from an illness phase to a remission/recovery state.
相似文献
Kenneth HugdahlEmail: |
57.
Targeting the LRP5 Pathway Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta 下载免费PDF全文
Christina M Jacobsen Lauren A Barber Ugur M Ayturk Heather J Roberts Lauren E Deal Marissa A Schwartz MaryAnn Weis David Eyre David Zurakowski Alexander G Robling Matthew L Warman 《Journal of bone and mineral research》2014,29(10):2297-2306
The cell surface receptor low‐density lipoprotein receptor‐related protein 5 (LRP5) is a key regulator of bone mass and bone strength. Heterozygous missense mutations in LRP5 cause autosomal dominant high bone mass (HBM) in humans by reducing binding to LRP5 by endogenous inhibitors, such as sclerostin (SOST). Mice heterozygous for a knockin allele (Lrp5p.A214V) that is orthologous to a human HBM‐causing mutation have increased bone mass and strength. Osteogenesis imperfecta (OI) is a skeletal fragility disorder predominantly caused by mutations that affect type I collagen. We tested whether the LRP5 pathway can be used to improve bone properties in animal models of OI. First, we mated Lrp5+/p.A214V mice to Col1a2+/p.G610C mice, which model human type IV OI. We found that Col1a2+/p.G610C;Lrp5+/p.A214V offspring had significantly increased bone mass and strength compared to Col1a2+/p.G610C;Lrp5+/+ littermates. The improved bone properties were not a result of altered mRNA expression of type I collagen or its chaperones, nor were they due to changes in mutant type I collagen secretion. Second, we treated Col1a2+/p.G610C mice with a monoclonal antibody that inhibits sclerostin activity (Scl‐Ab). We found that antibody‐treated mice had significantly increased bone mass and strength compared to vehicle‐treated littermates. These findings indicate increasing bone formation, even without altering bone collagen composition, may benefit patients with OI. © 2014 American Society for Bone and Mineral Research. 相似文献
58.
59.
60.
The amino acid intermediate homocysteine (Hcy) is formed during the metabolism of methionine to cysteine. Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for coronary atherosclerosis. The circulating levels of total Hcy (tHcy) can increase due to intake of foods rich in methionine or deficiencies of vitamins such as folate, pyridoxine and cyanocobalamin, which are required for the metabolism of Hcy. In addition, mutations in the genes coding for Hcy metabolizing enzymes can contribute to an increase in tHcy levels. Clinical and epidemiological studies have shown that an elevated level of tHcy measured in serum or plasma is a strong predictor of cardiovascular disease risk, which appears to be greatest in patients who have HHcy following a methionine load. Intimal hyperplasia (IH) (intima/media [I/M] ratio) is the universal response of a vessel to injury and may result in vasoconstriction when left unattended. The effect of dietary HHcy on balloon catheter-injured carotid artery and its modulation (if any) by the peroxisome proliferator-activated receptor agonist gamma rosiglitazone was evaluated in 12-week-old female Sprague-Dawley rats fed either a control diet or a diet containing 1% L-methionine. Once the rats were established on the diet, the group that was fed 1% L-methionine was further subdivided and either given an aqueous preparation of 3 mg/kg/day rosiglitazone or the vehicle via oral gavage for one week. This was followed by surgically injuring the left carotid artery using a Maverick Over-The-Wire catheter (2.0 mm × 20 mm, 3.2F; Boston Scientific, USA). The rats were continued on their respective diets and drug regimen for 21 days postsurgery. On day 22 of the procedure, the rats were sacrificed for collection of blood, the carotid arteries and liver for biochemical and histological evaluation. Compared with controls there was a significant increase in both tHcy levels and I/M ratio in the rats fed 1% L-methionine (5.4±0.28 μM versus 32.8±3.01 μM, P<0.002; and 0.175±0.05 versus 1.05±0.23, P<0.005, respectively). The effect of rosiglitazone in rats fed the control diet was not prominent. On the other hand, administration of rosiglitazone to the rats on the 1% L-methionine diet significantly reduced the levels of serum tHcy (16.6±2.1 μM versus 32.8±3.01 μM, P<0.001); however, the tHcy levels remained significantly elevated compared with animals on the control diet (P<0.002). The group receiving the L-methionine diet plus rosiglitazone had an inhibition in the development of IH compared with those receiving the L-methionine diet alone (I/M of 0.278±0.041 versus 1.05±0.23, P<0.01). Moreover, the development of IH in the group receiving the L-methionine diet plus rosiglitazone treatment was not significantly different from that observed in the group on the control diet without rosiglitazone (0.278±0.041 versus 0.175±0.05, respectively). These findings may have important implications in deciphering the molecular mechanisms involved in the augmentation of IH in HHcy and modulation of this process by rosiglitazone. 相似文献